Microbot Medical (MBOT) Return on Equity (2011 - 2026)

Microbot Medical (MBOT) has 16 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity rose 1.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (up 1.0% YoY), and the FY2025 full-year result was 0.0%, up 3.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
• Across five years, Return on Equity topped out at 0.0% in Q4 2025 and bottomed at 0.03% in Q4 2024.
• The 5-year median for Return on Equity is 0.02% (2024), against an average of 0.01%.
• The widest annual swing landed in 2022, when Return on Equity slipped 1 bps; it then increased 3 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.02% in 2022, then climbed by 21 bps to 0.02% in 2023, then sank by 92 bps to 0.03% in 2024, then surged by 94 bps to 0.0% in 2025, then fell by 8 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.

Peer Comparison